Vol 2017, No 8 (2017)

Table of Contents

Research & Development

AstraZeneca Signs Massive US$8.5 B Oncology Collaboration with Merck & Co Following Trial Failure Abstract pdf html
Daniel Roberts & Natasha Piper

Mergers & Acquisitions

Bristol-Myers Squibb Fights Immuno-oncology Competition with Early stage Biotech Acquisition Abstract pdf html
Natasha Piper
Mitsubishi Pharma Acquires NeuroDerm for Parkinson’s Drug Abstract pdf html
Jawala Prasad
Gilead Acquires CAR-T Oncology Specialist Kite for US$11.9 B Abstract pdf html
Daniel Roberts

Opinion & Analysis

IMS PharmaDeals: Half-Year Review of 2017 Abstract pdf
Heather Cartwright & Taskin Ahmed


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.